TEDIGLUTIDE ..Glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from radiation damage. | New Drug Approvals
GLP-2 Agonists for Short Bowel Syndrome - ScienceDirect
Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide Is Used To Treat Short-Bowel Syndrome, An Orphan Disease. Cartoon & Wire Representation. Secondary Structure Coloring. Stock Photo, Picture And Royalty Free
GLP-2 | gutsandgrowth
![PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfd69eccd23a9c8a10ba8cd828f6dc1685055d28/5-Figure1-1.png "PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar")
PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms | Arteriosclerosis, Thrombosis, and Vascular Biology
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
Current and potential therapeutic targets of glucagon-like peptide-2. | Semantic Scholar
Schematic representation of GLP-2 action in the gastrointestinal... | Download Scientific Diagram
Schematic representation of the action of GLP-2 on the enterocyte or on... | Download Scientific Diagram
Pipeline | R&D
Release of glucagon-like peptide (GLP)-2 by L cells. The L cell... | Download Scientific Diagram
Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice | American Journal of Physiology-Gastrointestinal and Liver Physiology
Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Stock Illustration - Illustration of polypeptide, glp2: 35580175
Glucagon.com
Compound details
Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system - ScienceDirect
Microorganisms | Free Full-Text | GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor | Cell Research
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure
